Food group Nestle cuts full-year outlook after sales miss

World’s largest packaged food company’s sales down 2.1% in year to September

Food giant Nestle lowered its full-year outlook on Friday after setbacks from a Maggi noodle recall in India and a rebate adjustment in its skin health division in the third quarter.
Food giant Nestle lowered its full-year outlook on Friday after setbacks from a Maggi noodle recall in India and a rebate adjustment in its skin health division in the third quarter.

Nestle lowered its full-year outlook on Friday as a Maggi noodle scandal continued to drag down third-quarter sales.

The world’s largest packaged food company’s sales dropped 2.1 per cent to 64.9 billion Swiss francs ($68.16 billion) in the nine months to September, missing analysts’ forecast of 65.9 billion francs in a Reuters poll.

"After a good performance in the first half of the year we were impacted in the third quarter by exceptional events, with Maggi noodles in India and a rebate adjustment in Nestle Skin Health," chief executive Paul Bulcke said.

Underlying “organic” growth - adjusted for currency swings, acquisitions and divestitures - slowed to 4.2 per cent in the first nine months from 4.5 per cent in the half-year, sliding further behind the company’s 5 per cent organic growth target for 2015.

READ SOME MORE

The company cut its 2015 outlook to around 4.5 per cent, below its long-term model calling for 5 to 6 per cent growth.

In the United States, chilled frozen food sales began warming after a major revamp of Nestle’s Lean Cuisine brand, but this was contrasted with lagging sales in China, which were showing slower sales recovery, Mr Bulcke said. India’s Maggi noodle recall continued to have a significant impact on growth in the South Asia Region, Nestle said.

In its skin health division, Nestle’s US prescription drug rebates exceeded the amount of money that was set aside for this purpose. This resulted in an additional one-off charge in the third quarter, it said.

Reuters